BUYINS.NET: Market Maker Surveillance Report. NFLX, CQB, ABIO, OPXA, CPRX, CLIR, Winning Stocks With Lowest Price Friction For Monday, April 22nd 2013
(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4011 companies with "abnormal" market making, 2610 companies with positive Friction Factors and 2394 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Netflix Inc (NASDAQ:NFLX), Chiquita Brands International Inc (NYSE:CQB), ARCA Biopharma Inc (NASDAQ:ABIO), Opexa Therapeutics Inc (NASDAQ:OPXA), Catalyst Pharmaceutical Partners Inc (NASDAQ:CPRX), Clearsign Combustion Corp (NASDAQ:CLIR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction
NFLX $43.000 26.32% 4,935,503 50.39% 4,841,157 49.43% 94,346 22
CQB $0.790 10.90% 400,325 44.10% 283,460 31.23% 116,865 1,479
ABIO $0.880 44.67% 1,169,965 49.87% 1,169,772 49.86% 193 2
OPXA $0.190 11.24% 126,937 51.04% 121,765 48.96% 5,172 272
CPRX $0.180 20.18% 4,311,885 51.60% 4,044,402 48.40% 267,483 14,860
CLIR $0.960 13.10% 117,477 56.93% 88,482 42.88% 28,995 302
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows NFLX with a dollar gain Monday of $43.00000 and a Friction Factor of 22 shares. That means that it only took 22 more shares of buying than selling to move NFLX higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
Netflix Inc (NASDAQ:NFLX) - Netflix, Inc. provides Internet television network service that enables subscribers to stream TV shows and movies directly on TVs, computers, and mobile devices in the United States and internationally. The company operates in three segments: Domestic Streaming, International Streaming, and Domestic DVD. The Domestic Streaming segment offers access to content delivered over the Internet to various connected devices, such as PCs, Macs, game consoles, smart TVs, Blu-ray players, hone theatre systems, Internet video players, digital video recorders, and mobile devices. The International Streaming segment engages in the streaming services primarily in Canada, Latin America, the United Kingdom, Ireland, Finland, Denmark, Sweden, and Norway. The Domestic DVD segment provides DVDs-by-mail subscription services. The company also provides standard definition DVDs and Blu-ray discs to its subscribers in the United States. The company was founded in 1997 and is headquartered in Los Gatos, California..
Chiquita Brands International Inc (NYSE:CQB) - Chiquita Brands International, Inc., together with its subsidiaries, markets and distributes bananas and fresh produce under the Chiquita and other brand names worldwide. It operates through three segments: Bananas, Salads and Healthy Snacks, and Other Produce. The Bananas segment engages in sourcing, transporting, marketing, and distributing bananas to retail customers and wholesalers. The Salads and Healthy Snacks segment offers packaged ready-to-eat salads under the Fresh Express and other labels; fresh vegetable and fruit ingredients used in foodservice; healthy snacks, including Chiquita Fruit Bites, a single-serve fruit snacks under the Chiquita brand name; and processed fruit ingredient products. This segment distributes approximately 170 retail value-added salad products to food retailers and approximately 35 healthy snacking products. It also sells fresh-cut produce, such as lettuce, tomatoes, spinach, cabbage, and onions to foodservice distributors who resell these products to foodservice operators, primarily quick-service restaurants. In addition, this segment is involved in purchasing, processing, packaging, and distributing various fresh-cut apples, pineapples, carrots, and other fresh produce products. It distributes approximately 80 fresh produce foodservice offerings, primarily to third-party distributors for resale to quick-service restaurants located in the U.S. The Other Produce segment engages in marketing and distributing fresh fruit and vegetables other than bananas, primarily pineapples, grapes, and avocados in Europe and North America. The company was founded in 1899 and is headquartered in Charlotte, North Carolina..
ARCA Biopharma Inc (NASDAQ:ABIO) - ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. The company s lead product candidate, Gencaro, is a pharmacologically unique beta-blocker and mild vasodilator that is being developed for the treatment of atrial fibrillation in patients with heart failure. The company has a commercialization and licensing agreement with Laboratory Corporation of America to develop, make, market, and sell diagnostic tests in connection with the medical prescription of Gencaro; and a collaboration agreement with Archemix Corporation for the discovery and development of novel aptamers with anti-coagulation activities. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado..
Opexa Therapeutics Inc (NASDAQ:OPXA) - Opexa Therapeutics, Inc., a biopharmaceutical company, engages in the development of patient-specific cellular therapies for the treatment of autoimmune diseases. The company s principal therapy consists of Tovaxin, a cellular immunotherapy, which is under clinical development and is intended for the treatment of secondary progressive multiple sclerosis (MS), and relapsing remitting MS. It develops cellular therapies based on its proprietary T-cell technology. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics was founded in 2003 and is based in The Woodlands, Texas..
Catalyst Pharmaceutical Partners Inc (NASDAQ:CPRX) - Catalyst Pharmaceutical Partners, Inc., a development-stage specialty pharmaceutical company, focuses on the development and commercialization of prescription drugs targeting diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy. It is evaluating, its lead product candidate, CPP-109, a GABA aminotransferase inhibitor candidate, which is under Phase II(b) clinical trial for the treatment of cocaine and methamphetamine addiction, as well as focuses on evaluating CPP-109 for the treatment of other addictions and other selected central nervous system indications. The company is also developing CPP-115, a GABA aminotransferase inhibitor in Phase I(a) trial for various indications, including drug addiction, epilepsy, and for other selected central nervous disease indications. It has license agreements with Brookhaven Science Associates, LLC on various patents and patent applications relating to the use of vigabatrin as a treatment for cocaine and other addictions, and obsessive-compulsive disorders. The company was founded in 2002 and is headquartered in Coral Gables, Florida..
Clearsign Combustion Corp (NASDAQ:CLIR) - .
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to firstname.lastname@example.org)).
(c) 2013 M2 COMMUNICATIONS
[ Back To Cloud Computing 's Homepage ]